Rhythm Pharmaceuticals, Inc. RYTM Proceeds from issuance of common stock relating to employee stock plans
Proceeds from issuance of common stock relating to employee stock plans at other companies
Other financials
Where this comes from
Reported directly by Rhythm Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:ProceedsFromStockPlans.
The official record: Rhythm Pharmaceuticals, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Rhythm Pharmaceuticals, Inc.'s proceeds from issuance of common stock relating to employee stock plans.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Rhythm Pharmaceuticals, Inc.'s proceeds from issuance of common stock relating to employee stock plans?
- Rhythm Pharmaceuticals, Inc. (RYTM) reported proceeds from issuance of common stock relating to employee stock plans of $1.25M in Q1 2026.
- How has Rhythm Pharmaceuticals, Inc.'s proceeds from issuance of common stock relating to employee stock plans changed year-over-year?
- Rhythm Pharmaceuticals, Inc.'s proceeds from issuance of common stock relating to employee stock plans increased by 46.5% year-over-year, from $854K to $1.25M.